The Phosphodiesterase-5 Inhibitors and Prostate Cancer – What We Rely Know About It?
Authors
Dejan Simic
Clinic of Urology, Military Medical Academy, Belgrade, Serbia
Aleksandar Spasic
Clinic of Urology, Military Medical Academy, Belgrade, Serbia
Mirko Jovanovic
Clinic of Urology, Military Medical Academy, Belgrade, Serbia
Predrag Maric
Clinic of Urology, Military Medical Academy, Belgrade, Serbia
Radovan Milosevic
Clinic of Urology, Military Medical Academy, Belgrade, Serbia
Ivan Srejovic
University of Kragujevac, Faculty of Medical Sciences, Department of Physiology, Kragujevac, Serbia
Language: English
Page range: 175 - 184
Submitted on: Dec 19, 2017
Accepted on: Dec 28, 2017
Published on: Jul 11, 2022
Published by: University of Kragujevac, Faculty of Medical Sciences
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
© 2022 Dejan Simic, Aleksandar Spasic, Mirko Jovanovic, Predrag Maric, Radovan Milosevic, Ivan Srejovic, published by University of Kragujevac, Faculty of Medical Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.